Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
S Romano, G Coarelli, C Marcotulli, L Leonardi… - The Lancet …, 2015 - thelancet.com
Background Our previous study in patients with cerebellar ataxias of different causes
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
S Romano, G Coarelli, C Marcotulli… - The Lancet …, 2015 - europepmc.org
Background Our previous study in patients with cerebellar ataxias of different causes
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
S Romano, G Coarelli, C Marcotulli, L Leonardi… - The Lancet …, 2015 - Elsevier
Background Our previous study in patients with cerebellar ataxias of different causes
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
Riluzole in patients with hereditary cerebellar ataxia. a randomised, double-blind, placebo-controlled trial
S Romano, G Coarelli, C Marcotulli… - LANCET …, 2015 - iris.uniroma1.it
BACKGROUND: Our previous study in patients with cerebellar ataxias of different causes
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
[引用][C] Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
S Romano, G Coarelli, C Marcotulli, L Leonardi… - The Lancet …, 2015 - cir.nii.ac.jp
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled
trial | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
trial | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
S Romano, G Coarelli, C Marcotulli, L Leonardi… - 2015 - pubmed.ncbi.nlm.nih.gov
Background Our previous study in patients with cerebellar ataxias of different causes
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
[PDF][PDF] Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
S Romano, G Coarelli, C Marcotulli, L Leonardi… - Lancet Neurol, 2015 - brain-team.fr
Background Our previous study in patients with cerebellar ataxias of different causes
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
S Romano, G Coarelli, C Marcotulli, L Leonardi… - The Lancet …, 2015 - infona.pl
Our previous study in patients with cerebellar ataxias of different causes showed significant
benefit of riluzole after 8 weeks. We aimed to confirm these results in patients with …
benefit of riluzole after 8 weeks. We aimed to confirm these results in patients with …
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
S Romano, G Coarelli, C Marcotulli, L Leonardi… - The Lancet …, 2015 - infona.pl
Our previous study in patients with cerebellar ataxias of different causes showed significant
benefit of riluzole after 8 weeks. We aimed to confirm these results in patients with …
benefit of riluzole after 8 weeks. We aimed to confirm these results in patients with …